BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21189322)

  • 21. Experimental transmission of field Anaplasma marginale and the A. centrale vaccine strain by Hyalomma excavatum, Rhipicephalus sanguineus and Rhipicephalus (Boophilus) annulatus ticks.
    Shkap V; Kocan K; Molad T; Mazuz M; Leibovich B; Krigel Y; Michoytchenko A; Blouin E; de la Fuente J; Samish M; Mtshali M; Zweygarth E; Fleiderovich EL; Fish L
    Vet Microbiol; 2009 Mar; 134(3-4):254-60. PubMed ID: 18823724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First molecular survey and novel genetic variants' identification of Anaplasma marginale, A. centrale and A. bovis in cattle from Tunisia.
    Belkahia H; Ben Said M; Alberti A; Abdi K; Issaoui Z; Hattab D; Gharbi M; Messadi L
    Infect Genet Evol; 2015 Aug; 34():361-71. PubMed ID: 26117444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic and proteomic approaches to vaccine candidate identification for Anaplasma marginale.
    Brayton KA; Palmer GH; Brown WC
    Expert Rev Vaccines; 2006 Feb; 5(1):95-101. PubMed ID: 16451111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Anaplasma centrale major surface protein-2 pseudogenes.
    Molad T; Leibovich B; Mazuz M; Fleiderovich L; Fish L; Shkap V
    Vet Microbiol; 2010 Jul; 143(2-4):277-83. PubMed ID: 20036077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.
    Noh SM; Turse JE; Brown WC; Norimine J; Palmer GH
    Clin Vaccine Immunol; 2013 May; 20(5):651-6. PubMed ID: 23446216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete genome sequence of Anaplasma marginale subsp. centrale.
    Herndon DR; Palmer GH; Shkap V; Knowles DP; Brayton KA
    J Bacteriol; 2010 Jan; 192(1):379-80. PubMed ID: 19854912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of antigenic differences that discriminate between cattle vaccinated with Anaplasma centrale and cattle naturally infected with Anaplasma marginale.
    Molloy JB; Bock RE; Templeton JM; Bruyeres AG; Bowles PM; Blight GW; Jorgensen WK
    Int J Parasitol; 2001 Feb; 31(2):179-86. PubMed ID: 11239938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular survey and genetic characterization of Anaplasma centrale, A. marginale and A. bovis in cattle from Algeria.
    Rjeibi MR; Ayadi O; Rekik M; Gharbi M
    Transbound Emerg Dis; 2018 Apr; 65(2):456-464. PubMed ID: 29034616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular detection and phylogenetic analysis of Anaplasma marginale and Anaplasma centrale amongst transhumant cattle in north-eastern Uganda.
    Byaruhanga C; Collins NE; Knobel DL; Khumalo ZTH; Chaisi ME; Oosthuizen MC
    Ticks Tick Borne Dis; 2018 Mar; 9(3):580-588. PubMed ID: 29422446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composition of the surface proteome of Anaplasma marginale and its role in protective immunity induced by outer membrane immunization.
    Noh SM; Brayton KA; Brown WC; Norimine J; Munske GR; Davitt CM; Palmer GH
    Infect Immun; 2008 May; 76(5):2219-26. PubMed ID: 18316389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the immune response to Anaplasma marginale MSP5 protein using a HSV-1 amplicon vector system or recombinant protein.
    Palacios C; Torioni de Echaide S; Mattion N
    Res Vet Sci; 2014 Dec; 97(3):514-20. PubMed ID: 25458492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Anaplasma marginale subsp. centrale Strains by Use of msp1aS Genotyping Reveals a Wildlife Reservoir.
    Khumalo ZT; Catanese HN; Liesching N; Hove P; Collins NE; Chaisi ME; Gebremedhin AH; Oosthuizen MC; Brayton KA
    J Clin Microbiol; 2016 Oct; 54(10):2503-12. PubMed ID: 27440819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
    Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
    PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity.
    Noh SM; Zhuang Y; Futse JE; Brown WC; Brayton KA; Palmer GH
    Vaccine; 2010 May; 28(21):3741-7. PubMed ID: 20199762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and field evaluation of an ELISA to differentiate
    Bellezze J; Thompson CS; Bosio AS; Torioni SM; Primo ME
    J Vet Diagn Invest; 2023 Mar; 35(2):204-208. PubMed ID: 36786319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and immune recognition of the conserved MSP4 outer membrane protein of Anaplasma marginale.
    Oberle SM; Palmer GH; Barbet AF
    Infect Immun; 1993 Dec; 61(12):5245-51. PubMed ID: 7693596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major histocompatibility complex class II DR-restricted memory CD4(+) T lymphocytes recognize conserved immunodominant epitopes of Anaplasma marginale major surface protein 1a.
    Brown WC; McGuire TC; Mwangi W; Kegerreis KA; Macmillan H; Lewin HA; Palmer GH
    Infect Immun; 2002 Oct; 70(10):5521-32. PubMed ID: 12228278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
    Sarli M; Novoa MB; Mazzucco MN; Signorini ML; Echaide IE; de Echaide ST; Primo ME
    PLoS One; 2020; 15(2):e0229301. PubMed ID: 32084216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals.
    Palmer GH; Futse JE; Leverich CK; Knowles DP; Rurangirwa FR; Brayton KA
    Infect Immun; 2007 Mar; 75(3):1502-6. PubMed ID: 17178787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid and long-term disappearance of CD4+ T lymphocyte responses specific for Anaplasma marginale major surface protein-2 (MSP2) in MSP2 vaccinates following challenge with live A. marginale.
    Abbott JR; Palmer GH; Kegerreis KA; Hetrick PF; Howard CJ; Hope JC; Brown WC
    J Immunol; 2005 Jun; 174(11):6702-15. PubMed ID: 15905510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.